Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:grapiprant
|
| gptkbp:approvedBy |
gptkb:FDA
2016 |
| gptkbp:ATCCode |
gptkb:QM01AX92
|
| gptkbp:drugClass |
gptkb:piprant
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galliprant
|
| gptkbp:manufacturer |
gptkb:Elanco
|
| gptkbp:mechanismOfAction |
EP4 prostaglandin receptor antagonist
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
vomiting
diarrhea anorexia lethargy |
| gptkbp:species |
gptkb:dog
|
| gptkbp:usedFor |
osteoarthritis pain in dogs
|
| gptkbp:bfsParent |
gptkb:Elanco_Animal_Health
|
| gptkbp:bfsLayer |
6
|